Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy

Julio A. Chirinos, Juan P. Zambrano, Simon Chakko, Alan Schob, Anila Veerani, Guido O. Perez, Armando J. Mendez

Research output: Contribution to journalArticle

32 Scopus citations

Abstract

The usefulness of serum C-reactive protein, an inflammatory marker, to predict mortality risk in patients who have ischemic cardiomyopathy was investigated. C-reactive protein was measured in 123 men who underwent cardiac catheterization and were noted to have left ventricular ejection fraction ≤45% and significant angiographic coronary artery disease. They were prospectively followed for 3 years. Higher levels of C-reactive protein were associated with increased mortality rate. This correlation was independent of other prognostic factors, such as age, ejection fraction, symptoms of severe congestive heart failure, use of angiotensin-converting enzyme inhibitors, and use of β blockers.

Original languageEnglish (US)
Pages (from-to)88-90
Number of pages3
JournalAmerican Journal of Cardiology
Volume95
Issue number1
DOIs
StatePublished - Jan 1 2005

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy'. Together they form a unique fingerprint.

  • Cite this